APYX News and Press, Apyx Medical Corporation From 09/13/22

'BOTCHED' TV STAR DR. PAUL NASSIF AMONG TOP U.S. PLASTIC SURGEONS USING RENUVION® HELIUM PLASMA TECHNOLOGY IN COSMETIC PROCEDURES PR Newswire Doctors Attest to Advanced Energy Technology Device's Transformative Solutions to Achieve Desired Results in Pat...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , announced today that management will participate in the Lake Street Best Ideas Growth Confer...

Apyx Medical Corporation (APYX) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Charles Goodwin – President and Chief Executive Officer Tara Semb – Chief Financial Officer Conference Call Participants Dave Tu...

Gainers: Terns Pharmaceuticals ( TERN ) +36% . Rani Therapeutics ( RANI ) +25% . AirSculpt Technologies ( AIRS ) +21% . Larimar Therapeutics ( LRMR ) +21% . Neptune Wellness ( NEPT ) +18% . Losers: PLx Pharma ( PLXP ...

Apyx Medical press release ( NASDAQ: APYX ): Q2 GAAP EPS of -$0.16 beats by $0.03 . Revenue of $10.3M (-8.2% Y/Y) misses by $0.26M . Shares -4.1% . For further details see: Apyx Medical GAAP EPS of -$0.16 beats by $0.03, revenue of $10.3M misses b...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today reported financial results for its second quarter ended June 30, 2022, and updated financial...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of proprietary helium plasma and radiofrequency technology products marketed and sold as Renuvion ® in the cosmetic surgery market and J-Plasma ® in the hospital surgical market,...

Gainers: Inotiv ( NOTV ) +18% . IO Biotech ( IOBT ) +16% . SOPHiA GENETICS ( SOPH ) +10% . Apyx Medical ( APYX ) +9% . Rhythm Pharmaceuticals ( RYTM ) +9% . Losers: Regulus Therapeutics ( RGLS ) -14% . Aerovate...

Apyx Medical ( NASDAQ: APYX ) said the U.S. Food and Drug Administration (FDA) granted 510(k) clearance to its Renuvion APR Handpiece for certain skin contraction procedures. The company noted that specifically, Renuvion is now indicated for use in subcutaneous de...

RENUVION® CLEARED BY FDA FOR NECK LAXITY PROCEDURES OFFERING PATIENTS A MINIMALLY INVASIVE OPTION TO ELIMINATE SAGGING NECK PR Newswire Exclusive Apyx Medical Device Delivers State-Of-The-Art Plasma Energy To Improve Appearance of Loose Skin on The Neck and Ch...